| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5de66fcc7c37934b48c684ca26e9cc0 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2018-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49667972a002e9137d675a5edfd1c0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ef41e999f167739a8a27eb3418ccec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d177fa4e6ae4454f2bbd81035c5d2247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb3bbc51697ab5730f0db97d661006bd |
| publicationDate |
2019-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NL-2020886-B1 |
| titleOfInvention |
T-cell based immunotherapy |
| abstract |
The present invention provides novel mechanisms for enhancing a T cell response in vivo, ex vivo or in vitro, particularly in the context of vaccination, adoptive cell therapy and T-cell based immunotherapies involving immune checkpoint blockade. Corresponding methods and uses are also described. |
| priorityDate |
2018-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |